Michael A S Jewett, MD, FRCSC

Dr. Michael Jewett is a Professor of Surgery (Urology) at the University of Toronto, a member of the Department of Surgical Oncology at PMH and a clinician investigator at UHN.

Dr. Jewett was the Chairman of the Division of Urology at the University of Toronto and Head of Urology at UHN/PMH from 1991 to 2002. He remains an active staff member of each, holds a number of administrative positions and conducts his research in both institutions.

Dr. Jewett received his MD from Queen's University in Kingston, Ontario and did his residency in urology at the University of Toronto under Dr. Charles Robson. He did further postgraduate training at Memorial Sloan Kettering Cancer Center in New York City in Uro-Oncology and Immunology before returning to the University of Toronto. He has done further training in clinical epidemiology at McMaster University.
Dr. Jewett is known for his contributions in the fields of testis cancer, bladder cancer and kidney cancer in particular as well as technology assessment and clinical informatics and holds research funding from peer review agencies. He is President-elect of the Canadian Urology Association.
Int J Cancer. 2019 Aug 29;:
Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM
Clin Oncol (R Coll Radiol). 2019 Aug 01;:
Kushnir I, Kirk L, Mallick R, Kim RH, Graham GE, Breau RH, Lattouf JB, Violette PD, Pautler SE, Care M, Kapoor A, Jewett MAS, Wood L, Tanguay S, Heng DYC, Basappa NS, So A, Pouliot F, Reaume NM
Clin Genet. 2019 Aug 01;:
Salama Y, Albanyan S, Szybowska M, Bullivant G, Gallinger B, Giles RH, Asa S, Badduke C, Chiorean A, Druker H, Ezzat S, Hannah-Shmouni F, Hernandez KG, Inglese C, Jani P, Kaur Y, Krema H, Krimus L, Laperriere N, Lichner Z, Mete O, Sit M, Zadeh G,...
Eur Urol Oncol. 2019 Jul;2(4):437-442
Chung P, O'Malley ME, Jewett MAS, Bedard PL, Panzarella T, Sturgeon J, Moore MJ, Hamilton R, Hansen AR, Anson-Cartwright L, Gospodarowicz M, Warde P
Eur Urol. 2019 Jun 18;:
De Bruijn RE, Mulders P, Jewett MA, Wagstaff J, Van Thienen JV, Blank CU, Van Velthoven R, Wood L, van Melick HE, Aarts MJ, Lattouf JB, Powles T, De Jong IJ, Rottey S, Tombal B, Marreaud S, Collette S, Collette L, Haanen JB, Bex A
J Clin Oncol. 2019 Jun 19;:JCO1900107
Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG
Can Urol Assoc J. 2019 Jun;13(6):166-174
Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA
Eur Urol Focus. 2019 May 22;:
Hamilton RJ, Jewett MAS, Warde P, Hansen A
Eur Urol Oncol. 2018 Aug;1(3):177-187
Mir MC, Capitanio U, Bertolo R, Ouzaid I, Salagierski M, Kriegmair M, Volpe A, Jewett MAS, Kutikov A, Pierorazio PM, Young Academic Urologists Kidney Cancer working group of the European Urological Association

Pages


 

Professor, Department of Surgery, University of Toronto
Farquharson Clinical Research Chair in Kidney Cancer Research